Name: Latest research reports of Zydus Wellness Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Zydus Wellness Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	05 Feb 2025	Zydus Wellness	BOB Capital Markets Ltd. Target	1912.60	1987.00	1798.90 (6.32%)	Target met	Hold	pdf post cache	Broker Report Zydus Wellness (HOLD): Margin focus over reinvestments BOB Capital Markets Ltd. Q3FY25 sales came in 2% above consensus while EBITDA was 2% lower due to 15bps lower-than-expected margins pdf Copy Link Share on Share on Share on Share on Alert
	05 Feb 2025	Eris Lifesciences	BOB Capital Markets Ltd. Target	1795.10	1418.00	1390.20 (29.13%)	Target met	Buy	pdf post cache	Broker Report Eris Lifesciences (BUY): First player to launch GLP products in India BOB Capital Markets Ltd. Base domestic growth at 12% vs IMP growth of 8% due to new product launches and price increase pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2025	Kajaria Ceramics	BOB Capital Markets Ltd. Reco Target	1041.50	1130.00	959.85 (8.51%)	8.50	Buy	pdf post cache	Broker Report Kajaria Ceramics (BUY): Weak Q3; upgrade to BUY on reasonable valuations BOB Capital Markets Ltd. Weak Q3 on sharp margin contraction due to weak demand in the retail market and high overhead costs of new bathware unit pdf Copy Link Share on Share on Share on Share on Alert
	03 Feb 2025	Divi's Laboratories	BOB Capital Markets Ltd. Reco Target	6667.00	6050.00	5884.10 (13.31%)	Target met	Hold	pdf post cache	Broker Report Divis Labs (HOLD): Back to higher growth trajectory BOB Capital Markets Ltd. Q3 sales/EBITDA/PAT were 0.6%/7.5%/22.3% above our estimates. PAT was higher than estimated due to the adoption of the new tax regime pdf Copy Link Share on Share on Share on Share on Alert
	03 Feb 2025	Greenlam Industries	BOB Capital Markets Ltd. Reco Target	240.25	500.00	562.80 (-57.31%)	Target met	Sell	pdf post cache	Broker Report Greenlam Industries (SELL): Dismal Q3; D/G to SELL on weak earnings and rich valuations BOB Capital Markets Ltd. Dismal Q3 on weak performance of laminates segment and slow ramp-up of plywood segment pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Sun Pharmaceutical	BOB Capital Markets Ltd. Reco Target	1687.80	2086.00	1742.20 (-3.12%)	23.59	Buy	pdf post cache	Broker Report Sun Pharma (BUY): Strong performance to continue BOB Capital Markets Ltd. Domestic sales grew by 14% in Q3FY25 driven partially by volume/new launches and price hikes. Strong domestic sales growth to continue pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	IndusInd Bank	BOB Capital Markets Ltd. Target	816.85	1190.00	1009.40 (-19.08%)	45.68	Buy	pdf post cache	Broker Report Indusind Bank (BUY): Missed on most metrics BOB Capital Markets Ltd. Subdued quarter with moderate growth in advances and deposits, MFI book under stress pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Marico	BOB Capital Markets Ltd.	691.20	695.00	694.20 (-0.43%)	Target met	Hold	pdf post cache	Broker Report Marico (HOLD): Managing inflation BOB Capital Markets Ltd. Compared to consensus, 3QFY25 sales were 2% lower (1% below our estimate) while EBITDA was 1% pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Bandhan Bank	BOB Capital Markets Ltd. Target	175.19	187.00	151.39 (15.72%)	Target met	Buy	pdf post cache	Broker Report Bandhan Bank (BUY): Other income aids PPOP; MFI stress persists BOB Capital Markets Ltd. PPOP aided by one-offs in other income, payouts under CGFMU and Assam Microfinance relief scheme pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Nestle	BOB Capital Markets Ltd. Target	2376.80	2470.00	2327.20 (2.13%)	Target met	Hold	pdf post cache	Broker Report Nestle India (HOLD): Managing profits amidst inflation BOB Capital Markets Ltd. NEST continues to manage profits amidst inflation in cocoa and coffee. Wheat and palm have also turned inflationary pdf Copy Link Share on Share on Share on Share on Alert
more loading

BOB Capital Markets Ltd. Broker Research reports

Latest broker research reports from BOB Capital Markets Ltd. buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

Zydus Wellness (HOLD): Margin focus over reinvestments

Eris Lifesciences (BUY): First player to launch GLP products in India

Kajaria Ceramics (BUY): Weak Q3; upgrade to BUY on reasonable valuations

Divis Labs (HOLD): Back to higher growth trajectory

Greenlam Industries (SELL): Dismal Q3; D/G to SELL on weak earnings and rich valuations

Sun Pharma (BUY): Strong performance to continue

Indusind Bank (BUY): Missed on most metrics

Marico (HOLD): Managing inflation

Bandhan Bank (BUY): Other income aids PPOP; MFI stress persists

Nestle India (HOLD): Managing profits amidst inflation

Advisor Screeners